Brookstone Capital Management Pfizer Inc Transaction History

Brookstone Capital Management

$5.32 Billion
Q2 2024

A detailed history of Brookstone Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Brookstone Capital Management holds 122,054 shares of PFE stock, worth $3.62 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

122,054

Previous 89,030 37.09%

Holding current value

$3.62 Million

Previous $2.47 Million 38.26%

% of portfolio

0.06%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$25.26 - $29.6 $834,186 - $977,510	33,024 Added 37.09%	122,054 $3.42 Million
Q1 2024 Apr 15, 2024	SELL	$25.89 - $29.73 $8.88 Million - $10.2 Million	-342,976 Reduced 79.39%	89,030 $2.47 Million
Q4 2023 Jan 11, 2024	SELL	$26.13 - $33.94 $531,640 - $690,543	-20,346 Reduced 4.5%	432,006 $12.4 Million
Q3 2023 Oct 20, 2023	BUY	$32.09 - $37.51 $6.81 Million - $7.97 Million	212,369 Added 88.49%	452,352 $15 Million
Q2 2023 Jul 11, 2023	BUY	$36.12 - $41.79 $5.05 Million - $5.85 Million	139,895 Added 139.77%	239,983 $8.8 Million
Q1 2023 Apr 18, 2023	SELL	$39.39 - $51.28 $170,637 - $222,144	-4,332 Reduced 4.15%	100,088 $4.08 Million
Q4 2022 Jan 09, 2023	BUY	$41.75 - $54.5 $120,657 - $157,505	2,890 Added 2.85%	104,420 $0
Q3 2022 Oct 13, 2022	SELL	$43.76 - $53.42 $132,374 - $161,595	-3,025 Reduced 2.89%	101,530 $4.27 Million
Q2 2022 Jul 11, 2022	SELL	$46.53 - $55.17 $71,377 - $84,630	-1,534 Reduced 1.45%	104,555 $5.56 Million
Q1 2022 Apr 12, 2022	SELL	$45.75 - $56.69 $2.96 Million - $3.67 Million	-64,792 Reduced 37.92%	106,089 $5.72 Million
Q4 2021 Jan 11, 2022	SELL	$41.32 - $61.25 $341,840 - $506,721	-8,273 Reduced 4.62%	170,881 $9.52 Million
Q3 2021 Nov 03, 2021	SELL	$39.25 - $50.42 $43,057 - $55,310	-1,097 Reduced 0.61%	179,154 $7.42 Million
Q2 2021 Jul 14, 2021	BUY	$35.91 - $40.68 $1.19 Million - $1.34 Million	33,061 Added 22.46%	180,251 $7.15 Million
Q1 2021 Apr 16, 2021	BUY	$33.49 - $37.77 $265,676 - $299,629	7,933 Added 5.7%	147,190 $5.33 Million
Q4 2020 Jan 13, 2021	BUY	$33.47 - $42.56 $402,911 - $512,337	12,038 Added 9.46%	139,257 $5.13 Million
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $985,901 - $1.16 Million	31,052 Added 32.29%	127,219 $4.67 Million
Q2 2020 Jul 21, 2020	SELL	$30.12 - $36.54 $503,847 - $611,241	-16,728 Reduced 14.82%	96,167 $3.15 Million
Q1 2020 Apr 14, 2020	SELL	$27.03 - $38.62 $571,900 - $817,121	-21,158 Reduced 15.78%	112,895 $3.69 Million
Q4 2019 Jan 29, 2020	SELL	$32.92 - $37.36 $294,370 - $334,073	-8,942 Reduced 6.25%	134,053 $5.25 Million
Q3 2019 Oct 18, 2019	BUY	$32.49 - $42.13 $148,089 - $192,028	4,558 Added 3.29%	142,995 $5.14 Million
Q2 2019 Jul 25, 2019	BUY	$36.98 - $41.52 $2.17 Million - $2.44 Million	58,814 Added 73.87%	138,437 $6 Million
Q1 2019 Apr 18, 2019	SELL	$37.5 - $41.2 $24,562 - $26,986	-655 Reduced 0.82%	79,623 $3.38 Million
Q4 2018 Feb 06, 2019	SELL	$38.47 - $43.86 $3.49 Million - $3.98 Million	-90,762 Reduced 53.06%	80,278 $3.5 Million
Q3 2018 Nov 05, 2018	SELL	$34.47 - $41.81 $990,943 - $1.2 Million	-28,748 Reduced 14.39%	171,040 $7.54 Million
Q2 2018 Aug 06, 2018	SELL	$32.98 - $35.16 $653,861 - $697,082	-19,826 Reduced 9.03%	199,788 $7.25 Million
Q1 2018 Apr 23, 2018	BUY	$31.91 - $37.02 $343,702 - $398,742	10,771 Added 5.16%	219,614 $7.79 Million
Q4 2017 Feb 07, 2018	BUY	$33.26 - $35.29 $223,407 - $237,042	6,717 Added 3.32%	208,843 $7.56 Million
Q3 2017 Oct 31, 2017	SELL	$31.0 - $34.15 $195,579 - $215,452	-6,309 Reduced 3.03%	202,126 $7.22 Million
Q2 2017 Aug 08, 2017	BUY	N/A	208,435	208,435 $7 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.

Account

Brookstone Capital Management Pfizer Inc Transaction History